| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |